Real-world use of cabazitaxel plus prednisone in patients with metastatic castration-resistant prostate cancer (mcrpc) PREVIOUSLY TREATED WITH DOCETAXEL: REGIONAL ANALYSIS
![Thumbnail](/xmlui/themes/Mirage2//images/thumbnails/thumn_cientif.png)
Fecha de publicación
2015Título de revista
Asia-Pacific Journal of Clinical Oncology
Tipo de contenido
Publicación de congreso
![](/xmlui/themes/Mirage2//images/final_lines.png)